Trials / Conditions / Optic Nerve Glioma
Optic Nerve Glioma
6 registered clinical trials studyying Optic Nerve Glioma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours NCT03326388 | Great Ormond Street Hospital for Children NHS Foundation Trust | Phase 1 / Phase 2 |
| Recruiting | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462 | Maastricht Radiation Oncology | — |
| Completed | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma NCT02839720 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas NCT02976441 | Washington University School of Medicine | EARLY_Phase 1 |
| Completed | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas NCT01837862 | Julie Krystal | Phase 1 / Phase 2 |
| Withdrawn | Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma NCT01260103 | Burzynski Research Institute | Phase 3 |